Thomas Herold

2.5k total citations
84 papers, 1.4k citations indexed

About

Thomas Herold is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Thomas Herold has authored 84 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 16 papers in Surgery. Recurrent topics in Thomas Herold's work include Lung Cancer Treatments and Mutations (14 papers), Cancer Genomics and Diagnostics (7 papers) and Electric Motor Design and Analysis (7 papers). Thomas Herold is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Cancer Genomics and Diagnostics (7 papers) and Electric Motor Design and Analysis (7 papers). Thomas Herold collaborates with scholars based in Germany, United States and Hungary. Thomas Herold's co-authors include Christian Paetzel, Kay Hameyer, T. Kalteis, Joachim Grifka, Martin Händel, Niels Zorger, L. Perlick, Kurt Werner Schmid, Stefan Feuerbach and Enno de Lange and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Thomas Herold

79 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Herold Germany 22 517 353 235 192 116 84 1.4k
Liat Appelbaum Israel 21 542 1.0× 250 0.7× 195 0.8× 163 0.8× 242 2.1× 59 1.6k
Young Ho Jung South Korea 21 382 0.7× 217 0.6× 189 0.8× 85 0.4× 92 0.8× 92 1.1k
Jinhua Huang China 19 260 0.5× 339 1.0× 269 1.1× 154 0.8× 265 2.3× 90 1.4k
Jan Persson Sweden 29 821 1.6× 283 0.8× 226 1.0× 84 0.4× 69 0.6× 155 3.0k
Hiroyuki Kojima Japan 20 741 1.4× 337 1.0× 232 1.0× 80 0.4× 134 1.2× 187 1.6k
Satoshi Hara Japan 24 421 0.8× 542 1.5× 571 2.4× 472 2.5× 97 0.8× 210 2.1k
Ken Kobayashi Japan 21 185 0.4× 149 0.4× 348 1.5× 284 1.5× 105 0.9× 140 1.5k
Lehn K. Weaver United States 16 209 0.4× 502 1.4× 276 1.2× 324 1.7× 157 1.4× 29 2.3k
Ryuichi Yoshida Japan 28 870 1.7× 354 1.0× 764 3.3× 297 1.5× 60 0.5× 180 2.4k
Christopher Cheng Singapore 23 637 1.2× 986 2.8× 128 0.5× 187 1.0× 196 1.7× 98 1.9k

Countries citing papers authored by Thomas Herold

Since Specialization
Citations

This map shows the geographic impact of Thomas Herold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Herold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Herold more than expected).

Fields of papers citing papers by Thomas Herold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Herold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Herold. The network helps show where Thomas Herold may publish in the future.

Co-authorship network of co-authors of Thomas Herold

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Herold. A scholar is included among the top collaborators of Thomas Herold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Herold. Thomas Herold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collaud, Stéphane, Uta Dirksen, Dirk Theegarten, et al.. (2025). Characterization of a novel sarcoma cell line with an EWSR1::POU2AF3 fusion. Pathology & Oncology Research. 31. 1611986–1611986.
2.
Schüler, Martin, J. Hense, Kaid Darwiche, et al.. (2024). Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy inEGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance. Journal of Nuclear Medicine. 65(6). 851–855. 3 indexed citations
3.
Theurer, Sarah, Thomas Herold, Frank Weber, et al.. (2023). Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma. Journal of Nuclear Medicine. 64(12). 1865–1868. 4 indexed citations
4.
Wiesweg, Marcel, Martin Metzenmacher, Wilfried Eberhardt, et al.. (2021). BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy. European Journal of Cancer. 149. 211–221. 12 indexed citations
5.
Walter, Robert, Balázs Hegedűs, Thomas Hager, et al.. (2020). Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma. Scientific Reports. 10(1). 18677–18677. 17 indexed citations
6.
Ting, Saskia, Henning Reis, Martin Metzenmacher, et al.. (2020). ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer. Lung Cancer. 149. 10–16. 9 indexed citations
7.
Stockhammer, Paul, Luca Hegedüs, Gábor Lotz, et al.. (2020). HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model. Lung Cancer. 144. 20–29. 15 indexed citations
8.
Wiesweg, Marcel, Thomas Herold, Martin Metzenmacher, et al.. (2019). Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation. Lung Cancer. 139. 165–168. 4 indexed citations
9.
Wiesweg, Marcel, Henning Reis, Moritz Goetz, et al.. (2018). Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 17(2). e331–e352. 10 indexed citations
10.
Herold, Thomas, Ulrich Krafft, Felix Bremmer, et al.. (2017). Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer. Pathology International. 67(12). 597–601. 13 indexed citations
11.
Heiß, Peter, Niels Zorger, Okka W. Hamer, et al.. (2009). Optimized Multidetector Computed Tomographic Protocol for the Diagnosis of Active Obscure Gastrointestinal Bleeding. Journal of Computer Assisted Tomography. 33(5). 698–704. 9 indexed citations
12.
Schepke, Michael, Reiner Wiest, Sebastian Flacke, et al.. (2008). Irbesartan Plus Low-Dose Propranolol Versus Low-Dose Propranolol Alone in Cirrhosis: A Placebo-Controlled, Double-Blind Study. The American Journal of Gastroenterology. 103(5). 1152–1158. 24 indexed citations
13.
Herold, Thomas. (2006). Lamotrigine as a possible cause of QRS prolongation in a patient with known seizure disorder. Canadian Journal of Emergency Medicine. 8(5). 361–364. 20 indexed citations
14.
Herold, Thomas, Okka W. Hamer, R. Hente, et al.. (2006). Indirect MR Arthrography of the Shoulder: Use of Abduction and External Rotation to Detect Full- and Partial-Thickness Tears of the Supraspinatus Tendon. Radiology. 240(1). 152–160. 45 indexed citations
15.
Kalteis, T., Martin Händel, Thomas Herold, et al.. (2005). Position of the acetabular cup—accuracy of radiographic calculation compared to CT-based measurement. European Journal of Radiology. 58(2). 294–300. 149 indexed citations
16.
Herold, Thomas, et al.. (2005). Recurrent Arthralgias in a Patient With Previous Mayaro Fever Infection. Southern Medical Journal. 98(4). 484–485. 38 indexed citations
17.
Herold, Thomas, Christian Paetzel, Markus Völk, et al.. (2004). Contrast-Enhanced Magnetic Resonance Angiography of the Carotid Arteries:. Investigative Radiology. 39(2). 65–72. 10 indexed citations
18.
Hung, Joseph C., Thomas Herold, & Raymond J. Gibbons. (1996). Optimal conditions of 99mTc eluate for the radiolabeling of 99mTc-sestamibi. Nuclear Medicine and Biology. 23(5). 599–603. 9 indexed citations
19.
Puchta, Holger, et al.. (1990). A new strain of potato spindle tuber viroid (PSTVd-N) exhibits major sequence differences as compared to all other PSTVd strains sequenced so far. Plant Molecular Biology. 15(3). 509–511. 42 indexed citations
20.
Herold, Thomas, Mrinal K. Dewanjee, & Heinz W. Wahner. (1985). Preparation of xenon-133 solution for intravenous administration. Journal of Nuclear Medicine Technology. 13(2). 72–75.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liat Appelbaum Breakdown of academic impact, for papers by Young Ho Jung Breakdown of academic impact, for papers by Jinhua Huang Breakdown of academic impact, for papers by Jan Persson Breakdown of academic impact, for papers by Hiroyuki Kojima Breakdown of academic impact, for papers by Satoshi Hara Breakdown of academic impact, for papers by Ken Kobayashi Breakdown of academic impact, for papers by Lehn K. Weaver Breakdown of academic impact, for papers by Ryuichi Yoshida Breakdown of academic impact, for papers by Christopher Cheng
Rankless by CCL
2026